Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin

References

• AbeSYoshizawaMNakanishiNElectrocardiographic abnormalities in patients receiving hemodialysisAm Heart J1996131113711448644592
   PubMed Web of Science ®Google Scholar
• AtarIKonasDAcikelSFrequency of atrial fibrillation and factors related to its development in dialysis patientsInt J Cardiol2006106475116321665
   PubMed Web of Science ®Google Scholar
• VazquezESanchez-PeralesCBorregoFInfluence of atrial fibrillation on the morbido-mortality of patients on hemodialysisAm Heart J200014088689011099992
   PubMed Web of Science ®Google Scholar
• DasMAronowWSMcClungJABelkinRNIncreased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insufficiencyCardiol Rev200614141716371761
   PubMedGoogle Scholar
• FabbianFCatalanoCLambertiniDClinical characteristics associated to atrial fibrillation in chronic hemodialysis patientsClin Nephrol20005423423911020022
   PubMed Web of Science ®Google Scholar
• GenovesiSPoglianiDFainiAPrevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patientsAm J Kidney Dis20054689790216253730
   PubMed Web of Science ®Google Scholar
• VazquezESanchez-PeralesCLozanoCComparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodiálysisAm J Cardiol20039286887114516897
   PubMed Web of Science ®Google Scholar
• Vazquez-Ruiz de CastroviejoaESanchez-PeralesCLozano-CabezasC[Incidence of atrial fibrillation in hemodialysis patients. A prospective long-term follow-up study]Rev Esp Cardiol20065977978416938226
   PubMed Web of Science ®Google Scholar
• The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation InvestigatorsN Engl J Med1990323150515112233931
   PubMed Web of Science ®Google Scholar
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trialsArch Intern Med1994154144914578018000
   PubMed Web of Science ®Google Scholar
• Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trialLancet19963486336388782752
   PubMed Web of Science ®Google Scholar
• Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study GroupLancet1993342125512627901582
   PubMed Web of Science ®Google Scholar
• PetersonPBoysenGGodtfredsenJPlacebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillationLancet198911751792563096
   PubMed Web of Science ®Google Scholar
• Preliminary report of the Stroke Prevention in Atrial Fibrillation StudyN Engl J Med19903228638682407959
   PubMed Web of Science ®Google Scholar
• Stroke Prevention in Atrial Fibrillation StudyFinal resultsCirculation1991845275391860198
   PubMed Web of Science ®Google Scholar
• ConnollySJLaupacisAGentMCanadian Atrial Fibrillation Anticoagulation (CAFA) StudyJ Am Coll Cardiol199118345355
   Web of Science ®Google Scholar
• EzekowitzMDBridgersSLJamesKEWarfarin in the prevention of stroke associated with nonrheumatic atrial fibrillationN Engl J Med1992327140614121406859
   PubMed Web of Science ®Google Scholar
• Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II StudyLancet19943436876917907677
   PubMed Web of Science ®Google Scholar
• GullovALKoefoedBGPetersenPFixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation. Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation StudyArch Intern Med1998158151315219679792
   PubMed Web of Science ®Google Scholar
• AronowWSAhnCKronzonIGutsteinHIncidence of new thromboembolic stroke in persons ≥62 years old with chronic atrial fibrillation treated with warfarin versus aspirinJ Am Geriatr Soc19994736636810078902
   PubMed Web of Science ®Google Scholar
• AronowWSAhnCKronzonIGutsteinHEffect of warfarin versus aspirin on the incidence of new thromboembolic stroke in older persons with chronic atrial fibrillation and abnormal and normal left ventricular ejection fractionAm J Cardiol2000851033103510760353
   PubMed Web of Science ®Google Scholar
• AronowWSAcute and chronic management of atrial fibrillation in patients with late-stage CKDAm J Kidney Dis20095370171019324248
   PubMed Web of Science ®Google Scholar
• LeveyASBoschJPLewisJBA more accurate method to estimate glomerular filtration rate from serum creatinine. A new predictive equationAnn Intern Med199913046147010075613
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation: Kidney Disease Outcome Quality Initiative (K/DOQI) clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratificationAm J Kidney Dis200239suppl 1S1S26611904577
   PubMed Web of Science ®Google Scholar
• Ruioz-NodarJMMarinFHurtadoJAAnticoagulant therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantationJ Am Coll Cardiol20085181883518294566
   PubMed Web of Science ®Google Scholar
• AbbottKCTrespalaciosFCTaylorAJAgodoaLYAtrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortalityBMC Nephrol20034112546711
   PubMedGoogle Scholar
• KorantzopoulosPKokkorisSLiuTProtopsaltisILiGGoudevenosJAAtrial fibrillation in end-stage renal diseasePacing Clin Electrophysiol2007301391139717976105
   PubMed Web of Science ®Google Scholar
• FusterVRydenLEAsingerRWACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summaryJ Am Coll Cardiol2001381231126511583910
   PubMed Web of Science ®Google Scholar
• VazquezESanchez-PeralesCGarcia-CortesJOught dialysis patients with atrial fibrillation be treated with oral anticoagulants?Int J Cardiol20038713513912559531
   PubMed Web of Science ®Google Scholar
• WrightJRKalraPAOught dialysis patients with atrial fibrillation be treated with oral anticoagulants?Int J Cardiol200387139141
   Web of Science ®Google Scholar
• ElliottMJZimmermanDHoldenRMWarfarin anticoagulation in hemodialysis patients: A systematic review of bleeding ratesAm J Kidney Dis20075043344017720522
   PubMed Web of Science ®Google Scholar
• QuinnRRNaimarkDMOliverMJShould hemodialysis patients undergo systemic anticoagulation? A cost-utility analysisAm J Kidney Dis20075042143217720521
   PubMed Web of Science ®Google Scholar
• AbbottKCNeffRTBohenEMNarayanRAnticoagulation for chronic atrial fibrillation in hemodialysis patients: which fruit from the decision tree?Am J Kidney Dis20075034534817720510
   PubMed Web of Science ®Google Scholar